Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun;241(12):1323-31.
doi: 10.1177/1535370216654227.

Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications

Affiliations
Review

Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications

Ben Brannick et al. Exp Biol Med (Maywood). 2016 Jun.

Abstract

Prediabetes is a state characterized by impaired fasting glucose or impaired glucose tolerance. Evidence is increasingly demonstrating that prediabetes is a toxic state, in addition to being a harbinger of future development of diabetes mellitus. This minireview discusses the pathophysiology and clinical significance of prediabetes, and approach to its management, in the context of the worldwide diabetes epidemic. The pathophysiologic defects underlying prediabetes include insulin resistance, β cell dysfunction, increased lipolysis, inflammation, suboptimal incretin effect, and possibly hepatic glucose overproduction. Recent studies have revealed that the long-term complications of diabetes may manifest in some people with prediabetes; these complications include classical microvascular and macrovascular disorders, and our discussion explores the role of glycemia in their development. Finally, landmark intervention studies in prediabetes, including lifestyle modification and pharmacologic treatment, are reviewed.

Keywords: Impaired fasting glucose; impaired glucose tolerance; macrovascular; microvascular; prediabetes complications; prevention.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathophysiology of prediabetes: skeletal muscle insulin resistance, impaired insulin secretion by the pancreatic β-cells, dysregulated hepatic glucose production and increased lipolysis are among the documented defects underlying the development of prediabetes. (A color version of this figure is available in the online journal.)
Figure 2
Figure 2
The toxic environment of prediabetes increases the risks for macrovascular and microvascular complications
Figure 3
Figure 3
Toxic pathways linking blood glucose levels to tissue damage in susceptible persons. Intracellular hyperglycemia activates the aldose reductase (polyol) pathway as well as other pathways involving advanced glycosylation, PKC activation and increased flux through nutrient-sensing the hexosamine pathway. These activated pathways further lead to induction of downstream processes that mediate fibrosis, vascular dysfunction, inflammation, free radical generation, and tissue damage. AGE: advanced glycosylation end products; eNOS: endothelial nitric oxide synthase; NF-kB: nuclear factor-kB; PAI-1: plasminogen activator inhibitor-1; PKC: protein kinase C; RAGE: receptor for AGE; TGF-b: transforming growth factor-b; UDP: uridine diphosphate; VEGF: vascular endothelial growth factor. (A color version of this figure is available in the online journal.)

References

    1. World Health Organization. Global status report on noncommunicable diseases 2014, Geneva, Switzerland: WHO Press, 2014.
    1. Hu F. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011; 34: 1249–57. - PMC - PubMed
    1. D’Adamo E, Caprio S. Type 2 diabetes in youth: epidemiology and pathophysiology. Diabetes Care 2011; 34: S161–5. - PMC - PubMed
    1. Bullard KM, Saydah SH, Imperatore G, Cowie CC, Gregg EW, Geiss LS, Cheng YJ, Rolka DB, Williams DE, Caspersen CJ. Secular changes in the U.S. prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: National Health and Nutrition Examinations Surveys, 1999–2010. Diabetes Care 2013; 36: 2286–93. - PMC - PubMed
    1. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Sayday SH, Geiss LS. Full accounting of diabetes and prediabetes in the US population 1988–1994 and 2005–2006. Diabetes Care 2009; 32: 287–94. - PMC - PubMed

Publication types